POPULAR SECTIONS

TREATMENT REGIMENS DRUG INFO MEDICAL CALCULATORS PUBLISHERS ALLIANCE VIDEOS CME

Latest News

Biomarker May Predict Response to Sorafenib in Patients with Liver Cancer

Biomarker May Predict Response to Sorafenib in Patients with Liver Cancer

Patients with liver cancer whose tumors cells have less differentiated mesenchymal phenotype and CD44 are less likely to respond to sorafenib.

DOST Imaging May Predict Breast Cancer Response to Chemotherapy

DOST Imaging May Predict Breast Cancer Response to Chemotherapy

Diffuse Optical imaging (DOST) may be effective for predicting which breast cancer patients will achieve the best response to chemotherapy.

FOLFOXIRI with Bevacizumab Aids Metastatic Colorectal Cancer Outcomes

FOLFOXIRI with Bevacizumab Aids Metastatic Colorectal Cancer Outcomes

Findings show benefits compared with FOLFIRI for patients with untreated metastatic colorectal cancer disease.

Coping Strategies Common for Cancer-Related Financial Distress

Coping Strategies Common for Cancer-Related Financial Distress

Most cancer patients use lifestyle-altering strategies and about 40 percent adopt care-altering strategy.

Unplanned Hospitalizations for Gastrointestinal Cancers Common

Unplanned Hospitalizations for Gastrointestinal Cancers Common

Top reasons for gastrointestinal cancer hospitalization include electrolyte disorders, intestinal obstruction, pneumonia.

For Patients With Bladder Cancer, Inadequate Biopsies May Increase 5-Year Mortality

For Patients With Bladder Cancer, Inadequate Biopsies May Increase 5-Year Mortality

Patients with bladder cancer who did not receive an optimal biopsy were more likely to die from their disease.

Researchers Identify Neo-Antigens as Potential Targets for Personalized Immunotherapy

Researchers Identify Neo-Antigens as Potential Targets for Personalized Immunotherapy

Researchers identified potential new targets for personalized cancer vaccines.

Hospice Care Has No Effect on Terminal Ovarian Cancer Treatment

Hospice Care Has No Effect on Terminal Ovarian Cancer Treatment

Findings among older patients with terminal ovarian cancer receiving hospice care.

Phase 3 Trial to Determine Safety, Efficacy of Nintedanib in Patients with Colorectal Cancer Has Begun

Phase 3 Trial to Determine Safety, Efficacy of Nintedanib in Patients with Colorectal Cancer Has Begun

Boehringer has enrolled the first in a global phase 3 trial investigating nintedanib in metastatic colorectal cancer.

For Patients With Advanced Non-Small Cell Lung Cancer (NSCLC), Dacomitinib Not Superior to Erlotinib

For Patients With Advanced Non-Small Cell Lung Cancer (NSCLC), Dacomitinib Not Superior to Erlotinib

Researchers have found that dacomitinib was not superior to erlotinib in patients with advanced non-small cell lung cancer (NSCLC).

For Patients With HER2-Positive Breast Cancer, Trastuzumab Improves Survival

For Patients With HER2-Positive Breast Cancer, Trastuzumab Improves Survival

Addition of trastuzumab (Herceptin) to chemo for breast cancer improves survival.

For Patients with Metastatic Castration-Resistant Prostate Cancer, Abiraterone Delays Disease Progression

For Patients with Metastatic Castration-Resistant Prostate Cancer, Abiraterone Delays Disease Progression

Abiraterone significantly improves progression-free survival in metastatic castration-resistant prostate cancer (mCRPC).

Prostate Cancer Detected by Long Noncoding RNA

Prostate Cancer Detected by Long Noncoding RNA

Markers successfully detected prostate cancer in patient urine samples and up-regulated versus normal urine.

70-Gene Signature in Breast Cancer Not Cost-Effective

70-Gene Signature in Breast Cancer Not Cost-Effective

Findings in comparative economic analysis of patients with node-negative breast cancer.

Copper Plus Disulfiram May Be Effective For Men with Progressive Prostate Cancer

Copper Plus Disulfiram May Be Effective For Men with Progressive Prostate Cancer

Administering copper and a drug that kills copper-containing cells in prostate cancer.

More News

Health Care Expenditure Slowed in US

Health sector prices explain much of difference between U.S. and other high-spending countries.

States Concerned About Higher-Than-Expected Medicaid Enrollment

Millions signing up for Medicaid to comply with federal health care law.

EHR Use More Than Doubles

Almost 80% of doctors in the United States have switched from paper to electronic health records.

Many Docs Order Unnecessary Medical Tests

Most physicians believe that doctors order too many medical tests, yet half admit to doing so themselves in response to a patient who insists, a new survey shows.

Reducing Six Risk Factors May Prevent 37 Million Deaths

Several modifiable risk factors can cut chronic disease deaths over the next 15 years.

Majority of Women Lack Accurate Knowledge of Their Own Breast Cancer Risk

Caucasian women overestimate their risk of breast cancer while African American and Hispanic women underestimate their risk, according to research presented at BCS 2013.

Survey Identifies Modifiable Barriers to Mammography Screening Among Rural US Women

A survey presented at BCS 2013 has found a number of factors that cause rural US women to avoid breast cancer screening.

Perioperative MRI of Uncertain Benefit for Women with DCIS

The benefit of perioperative MRI for women with ductal carcinoma in situ (DCIS) is "uncertain," found a study presented during BCS 2013.

Dr. Edith Perez's Recommended Abstracts at BCS 2013

ChemotherapyAdvisor.com Editorial Board member Dr. Edith Perez of the Mayo Clinic, Jacksonville, FL, recommends high impact abstracts at the Breast Cancer Symposium 2013.

Radiotherapy for DCIS Is Not Associated With Increased Cardiovascular Disease

Women who underwent radiation for ductal carcinoma in situ do not face an increased risk of cardiovascular disease, found a study presented at BCS 2013.

Sign Up for Free e-newsletters

Community Poll

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs